Public Healthcare Procurement Strategies in Response to the COVID-19 Pandemic: A Scoping Review

Document Type : Review Article

Authors

1 Département de Management, Faculté de Sciences de l’administration, Université Laval, Québec City, QC, Canada

2 Centre de Recherche en Gestion des Services de Santé, Université Laval, Québec City, QC, Canada

3 Centre de Recherche de l’Institut de Cardio-Pneumologie de Québec, Université Laval, Québec City, QC, Canada

4 Centre de Recherche du CHU de Québec, Université Laval, Québec City, QC, Canada

5 Centre de recherche du CIUSSS de Chaudière-Appalaches, Québec City, QC, Canada

6 VITAM, Centre de Recherche en Santé Durable, Université Laval, Québec City, QC, Canada

7 Bibliothèque-Direction des Servicesconseils, Université Laval, Québec City, QC, Canada

Abstract

Background 
The COVID-19 pandemic posed unprecedented public healthcare procurement challenges. The objective of this review was to identify and characterise the scope of the literature on public procurement strategies for healthcare supplies during the COVID-19 pandemic (2019–2023) in relation to the public procurement contexts, systems, and processes and methods (the public procurement ecosystem) worldwide.
 
Methods 
We performed a scoping review of governmental strategies for the procurement of medical equipment, personal protective equipment (PPE), or medications related to the COVID-19 pandemic. Extracted data were mapped to the fields of the public procurement ecosystem. We used inductive thematic analysis to derive within-field themes, and subsequently, cross-cutting themes through which we structured a narrative synthesis.
 
Results 
1909 unique studies were identified through a systematic search, of which 89 met the inclusion criteria. One hundred and ten themes were derived from the extracted data within the 21 fields of the public procurement ecosystem, and from these, 10 cross-cutting themes were identified which served to structure the narrative synthesis. It was clear in this literature that the scale and impact of the COVID-19 pandemic required governments to act well outside of the public procurement processes and methods themselves, to procure and distribute the required supplies. Notwithstanding the significant attention to contextual and system-level responses, there were significant responses at the procurement process and methods level, including rapid and temporary expedited procurement processes and longer-term strategic procurement responses.
 
Conclusion 
This scoping review of public procurement strategies during the COVID-19 pandemic has demonstrated a focus of the literature not only on the public procurement processes and methods themselves, but also on governmental actions to adapt both structures of public procurement systems and conditions within broader environmental contexts to facilitate procurement goals. 

Keywords

References

  1. World Health Organization (WHO). WHO Director-General’s Opening Remarks at the Media Briefing - 5 May 2023. WHO; 2023. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing---5-may-2023. Accessed May 29, 2025.
  2. World Health Organization (WHO). WHO Director-General Dr Tedros End of 2023 Message: Keeping the Hope for Health Alive. WHO; 2023. https://www.who.int/director-general/speeches/detail/who-director-general-dr-tedros-end-of-2023-message--keeping-the-hope-for-health-alive. Accessed May 29, 2025.
  3. World Health Organization (WHO). Coronavirus Disease (COVID-19) Pandemic. https://www.who.int/europe/emergencies/situations/covid-19. Accessed November 10, 2022.
  4. Lee VJ, Chiew CJ, Khong WX. Interrupting transmission of COVID-19: lessons from containment efforts in Singapore. J Travel Med. 2020;27(3):taaa039. doi:1093/jtm/taaa039
  5. Feng Z, Zhang Y, Pan Y, Zhang D, Zhang L, Wang Q. Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy. Med Rev (2021). 2022;2(2):197-212. doi:1515/mr-2021-0024
  6.  Masks4All. What Countries Require Masks in Public or Recommend Masks? https://masks4all.co/what-countries-require-masks-in-public/. Accessed November 16, 2022.
  7. Cohen J, Rodgers YVM. Contributing factors to personal protective equipment shortages during the COVID-19 pandemic. Prev Med. 2020;141:106263. doi:1016/j.ypmed.2020.106263
  8. Thai K. International Handbook of Public Procurement. 1st ed. Taylor and Francis; 2017. https://www.perlego.com/book/1580316/international-handbook-of-public-procurement-pdf.
  9. Kumar A, Ozdamar L, Ng CP. Procurement performance measurement system in the health care industry. Int J Health Care Qual Assur Inc Leadersh Health Serv. 2005;18(2-3):152-166. doi:1108/09526860510588179
  10. van Weele AJ. Purchasing and Supply Chain Management: Analysis, Planning and Practice. 2nd ed. Business Press; 2000.
  11. Schapper PR, Veiga Malta JN, Gilbert DL. An analytical framework for the management and reform of public procurement. J Public Procure. 2006;6(1-2):1-26. doi:1108/jopp-06-01-02-2006-b001
  12. Bortoletto G. Rules and Discretion in Standard and Emergency Public Procurement. 2021. https://thesis.unipd.it/retrieve/f7ea58d7-3b21-4bb9-9c9b-b1ea1453bb08/Bortoletto_Gianluca.pdf. Accessed May 12, 2024.
  13. Peterson J, Pearce PF, Ferguson LA, Langford CA. Understanding scoping reviews: definition, purpose, and process. J Am Assoc Nurse Pract. 2017;29(1):12-16. doi:1002/2327-6924.12380
  14. da Silva RM, Caetano R, Luiza VL, et al. Procurement management of strategic inputs in coping with COVID-19: scoping review protocol. Res Soc Dev. 2022;11(3):e3111326233. doi:33448/rsd-v11i3.26233
  15. Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467-473. doi:7326/m18-0850
  16. Chapter 11: Scoping reviews - JBI Manual for Evidence Synthesis - JBI Global Wiki. https://jbi-global-wiki.refined.site/space/MANUAL/4687342/Chapter+11%3A+Scoping+reviews. Accessed November 10, 2022.
  17. McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40-46. doi:1016/j.jclinepi.2016.01.021
  18. Veritas Health Information. Covidence Systematic Review Software. https://www.covidence.org/.
  19. Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Baldini Soares C. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13(3):141-146. doi:1097/xeb.0000000000000050
  20. Peters MD, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil H. Chapter 11: scoping reviews. JBI Manual for Evidence Synthesis. 2020;169(7):467-473.
  21. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:1136/bmj.n71
  22. Handfield R, Finkenstadt DJ, Schneller ES, Godfrey AB, Guinto P. A commons for a supply chain in the post-COVID-19 era: the case for a reformed strategic national stockpile. Milbank Q. 2020;98(4):1058-1090. doi:1111/1468-0009.12485
  23. Vecchi V, Cusumano N, Boyer EJ. Medical supply acquisition in Italy and the United States in the era of COVID-19: the case for strategic procurement and public-private partnerships. Am Rev Public Adm. 2020;50(6-7):642-649. doi:1177/0275074020942061
  24. Bhaskar S, Tan J, Bogers M, et al. At the epicenter of COVID-19-the tragic failure of the global supply chain for medical supplies. Front Public Health. 2020;8:562882. doi:3389/fpubh.2020.562882
  25. Gereffi G. What does the COVID-19 pandemic teach us about global value chains? The case of medical supplies. J Int Bus Policy. 2020;3(3):287-301. doi:1057/s42214-020-00062-w
  26. Atkinson CL, McCue C, Prier E, Atkinson AM. Supply chain manipulation, misrepresentation, and magical thinking during the COVID-19 pandemic. Am Rev Public Adm. 2020;50(6-7):628-634. doi:1177/0275074020942055
  27. Sadiq AA, Kessa R. US procurement in the age of COVID-19: challenges, intergovernmental collaboration, and recommendations for improvement. Am Rev Public Adm. 2020;50(6-7):635-641. doi:1177/0275074020942060
  28. Wang X, Wu W, Song P, He J. An international comparison analysis of reserve and supply system for emergency medical supplies between China, the United States, Australia, and Canada. Biosci Trends. 2020;14(4):231-240. doi:5582/bst.2020.03093
  29. Evenett SJ. Sicken thy neighbour: the initial trade policy response to COVID‐19. World Econ. 2020;43(4):828-839. doi:10.1111/twec.12954
  30. Rowan NJ, Laffey JG. Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (PPE) arising from Coronavirus disease (COVID19) pandemic - case study from the Republic of Ireland. Sci Total Environ. 2020;725:138532. doi:1016/j.scitotenv.2020.138532
  31. Kumar A, Luthra S, Mangla SK, Kazançoğlu Y. COVID-19 impact on sustainable production and operations management. Sustain Oper Comput. 2020;1:1-7. doi:1016/j.susoc.2020.06.001
  32. Francis JR. COVID-19: implications for supply chain management. Front Health Serv Manage. 2020;37(1):33-38. doi:1097/hap.0000000000000092
  33. Lau YY, Jiamian Z, Ng Adolf KY, Panahi R. Implications of a pandemic outbreak risk: a discussion on China’s emergency logistics in the era of coronavirus disease 2019 (COVID-19). J Int Logist Trade. 2020;18(3):127-135. doi:24006/jilt.2020.18.3.127
  34. Alazzam FAF, Saleh AJ, Aldrou K. Impact of pandemic COVID-19 on the legal regulation of world trade activity using the example of the medical supplies. Wiad Lek. 2020;73(7):1521-1527.
  35. Farca LA, Dragos D. Resilience in times of pandemic: is the public procurement legal framework fit for purpose? Transylv Rev Adm Sci. 2020;16(SI):60-79. doi:24193/tras.SI2020.4
  36. Kimura F, Thangavelu SM, Narjoko D, Findlay C. Pandemic (COVID-19) policy, regional cooperation and the emerging global production network. Asian Econ J. 2020;34(1):3-27. doi:1111/asej.12198
  37. Lee E, Chen YY, McDonald M, O’Neill E. Dynamic response systems of healthcare mask production to COVID-19: a case study of Korea. Systems. 2020;8(2):18. doi:3390/systems8020018
  38. Pauwelyn J. Export restrictions in times of pandemic: options and limits under international trade agreements. J World Trade. 2020;54(5):727-747. doi:54648/trad2020031
  39. Finkenstadt DJ, Handfield R. Blurry vision: supply chain visibility for personal protective equipment during COVID-19. J Purch Supply Manag. 2021;27(3):100689. doi:1016/j.pursup.2021.100689
  40. Curran L, Eckhardt J, Lee J. The trade policy response to COVID-19 and its implications for international business. Crit Perspect Int Bus. 2021;17(2):252-320. doi:1108/cpoib-05-2020-0041
  41. Sian S, Smyth S. Supreme emergencies and public accountability: the case of procurement in the UK during the COVID-19 pandemic. Account Audit Account J. 2022;35(1):146-157. doi:1108/aaaj-08-2020-4860
  42. Rutkowski CJ, Eboch K, Carr A, Greer BM. Strategic procurement collaboration for the common good: private and public procurement relationship during a pandemic. J Public Procure. 2022;22(1):43-63. doi:1108/jopp-10-2020-0076
  43. Tip B, Vos FG, Peters E, Delke V. A Kraljic and competitive rivalry perspective on hospital procurement during a pandemic (COVID-19): a Dutch case study. J Public Procure. 2022;22(1):64-88. doi:1108/jopp-11-2020-0081
  44. Bikkina S, Kittu Manda V, Adinarayana Rao UV. WITHDRAWN: medical oxygen supply during COVID-19: a study with specific reference to State of Andhra Pradesh, India. Mater Today Proc. 2021. doi:1016/j.matpr.2021.01.196
  45. Okeagu CN, Reed DS, Sun L, et al. Principles of supply chain management in the time of crisis. Best Pract Res Clin Anaesthesiol. 2021;35(3):369-376. doi:1016/j.bpa.2020.11.007
  46. Snowdon AW, Forest PG. "Flying blind": Canada's supply chain infrastructure and the COVID-19 pandemic. Healthc Q. 2021;23(4):12-16. doi:12927/hcq.2020.26399
  47. Unruh L, Allin S, Marchildon G, et al. A comparison of 2020 health policy responses to the COVID-19 pandemic in Canada, Ireland, the United Kingdom and the United States of America. Health Policy. 2022;126(5):427-437. doi:1016/j.healthpol.2021.06.012
  48. Antonini MJ, Plana D, Srinivasan S, et al. A crisis-responsive framework for medical device development applied to the COVID-19 pandemic. Front Digit Health. 2021;3:617106. doi:3389/fdgth.2021.617106
  49. Snowdon AW, Saunders M, Wright A. Key characteristics of a fragile healthcare supply chain: learning from a pandemic. Healthc Q. 2021;24(1):36-43. doi:12927/hcq.2021.26467
  50. Aljadeed R, AlRuthia Y, Balkhi B, et al. The impact of COVID-19 on essential medicines and personal protective equipment availability and prices in Saudi Arabia. Healthcare (Basel). 2021;9(3):290. doi:3390/healthcare9030290
  51. Del Castillo-Rodríguez C, Enríquez-Fernández S. Scientific uncertainty and guarantee of supply of medicines and healthcare products during the crisis caused by the SARS-CoV-2 in Spain. J Law Med. 2021;28(2):439-448.
  52. Evenett S, Fiorini M, Fritz J, et al. Trade policy responses to the COVID-19 pandemic crisis: evidence from a new data set. World Econ. 2022;45(2):342-364. doi:1111/twec.13119
  53. Kuo CC. COVID-19 in Taiwan: economic impacts and lessons learned. Asian Econ Pap. 2021;20(2):98-117. doi:1162/asep_a_00805
  54. Kuo S, Ou HT, Wang CJ. Managing medication supply chains: lessons learned from Taiwan during the COVID-19 pandemic and preparedness planning for the future. J Am Pharm Assoc (2003). 2021;61(1):e12-e15. doi:1016/j.japh.2020.08.029
  55. Lopez WB, Suarez DP, Espin GR, Alvarez ND. Control actions for risk prevention in emergency situations in the public sector. Rev Univ Soc. 2021;13:319-327.
  56. Ortiz-Prado E, Fernandez-Naranjo R, Torres-Berru Y, Lowe R, Torres I. Exceptional prices of medical and other supplies during the COVID-19 pandemic in Ecuador. Am J Trop Med Hyg. 2021;105(1):81-87. doi:4269/ajtmh.21-0221
  57. Abutabenjeh S, Anguelov L, Brunjes BM, Dimand AM, Rodriguez-Plesa E. Supplying the pandemic response: the importance of public procurement. J Emerg Manag. 2021;18(7):189-208. doi:5055/jem.0549
  58. Barber A, Vinzent A, Williams I. Management of personal protective equipment during the COVID-19 pandemic in England and the state of New York: a comparative case study. J Emerg Manag. 2021;18(7):71-89. doi:5055/jem.0531
  59. Beetsma R, Burgoon B, Nicoli F, de Ruijter A, Vandenbroucke F. Public support for European cooperation in the procurement, stockpiling and distribution of medicines. Eur J Public Health. 2021;31(2):253-258. doi:1093/eurpub/ckaa201
  60. Cambien G, Guihenneuc J, Fouassin X, Castel O, Bousseau A, Ayraud-Thevenot S. Management of donations of personal protective equipment in response to the massive shortage during the COVID-19 health crisis: providing quality equipment to health care workers. Antimicrob Resist Infect Control. 2021;10(1):159. doi:1186/s13756-021-01028-0
  61. Dallas MP, Horner R, Li L. The mutual constraints of states and global value chains during COVID-19: the case of personal protective equipment. World Dev. 2021;139:105324. doi:1016/j.worlddev.2020.105324
  62. Fu J, McMahon JA. The global scramble for PPE amid COVID-19: lessons from the EU export restrictions and import facilitation through regulatory cooperation on PPE. Asian J WTO Int Health Law Policy. 2021;16(1):25-58.
  63. Harland CM, Knight L, Patrucco AS, et al. Practitioners' learning about healthcare supply chain management in the COVID-19 pandemic: a public procurement perspective. Int J Oper Prod Manag. 2021;41(13):178-189. doi:1108/ijopm-05-2021-0348
  64. Hughes A, Brown JA, Trueba M, et al. Global value chains for medical gloves during the COVID-19 pandemic: confronting forced labour through public procurement and crisis. Glob Netw (Oxf). 2023;23(1):132-149. doi:1111/glob.12360
  65. Liu CM, Lee CT, Chou SM, et al. Strategies for supplying face masks to the population of Taiwan during the COVID-19 pandemic. BMC Public Health. 2021;21(1):1854. doi:1186/s12889-021-11808-3
  66. Morales-Contreras MF, Leporati M, Fratocchi L. The impact of COVID-19 on supply decision-makers: the case of personal protective equipment in Spanish hospitals. BMC Health Serv Res. 2021;21(1):1170. doi:1186/s12913-021-07202-9
  67. Park J, Chung E. Learning from past pandemic governance: early response and public-private partnerships in testing of COVID-19 in South Korea. World Dev. 2021;137:105198. doi:1016/j.worlddev.2020.105198
  68. Sawyer M. Economic policies and the coronavirus crisis in the UK. Rev Polit Econ. 2021;33(3):414-431. doi:1080/09538259.2021.1897254
  69. Scala B, Lindsay CF. Supply chain resilience during pandemic disruption: evidence from healthcare. Supply Chain Manag. 2021;26(6):672-688. doi:1108/scm-09-2020-0434
  70. Schnabel J, Hegele Y. Explaining intergovernmental coordination during the COVID-19 pandemic: responses in Australia, Canada, Germany, and Switzerland. Publius J Federalism. 2021;51(4):537-569. doi:1093/publius/pjab011
  71. Tai YL, Chi H, Chiu NC, Tseng CY, Huang YN, Lin CY. The effect of a name-based mask rationing plan in Taiwan on public anxiety regarding a mask shortage during the COVID-19 pandemic: observational study. JMIR Form Res. 2021;5(1):e21409. doi:2196/21409
  72. Weinman B, Levine GH, McCarthy J, Sims G. The American medical product supply chain: will COVID-19 drive manufacturing back home? Food Drug Law J. 2021;76(2):235-269.
  73. Anjos MD. Public procurement in times of pandemic Covid 19: the exception regime in Portuguese law and times of change in E.U. In: 4th International Conference Contemporary Challenges in Administrative Law from an Interdisciplinary Perspective; 2021:196-204.
  74. Baloch G, Gzara F, Elhedhli S. COVID-19 PPE distribution planning with demand priorities and supply uncertainties. Comput Oper Res. 2022;146:105913. doi:1016/j.cor.2022.105913
  75. Beaulieu M, Roy J, Rebolledo C, Landry S. The management of personal protective equipment during the COVID-19 pandemic: the case of the province of Quebec. Healthc Manage Forum. 2022;35(2):48-52. doi:1177/08404704211053996
  76. Borghi J, Brown GW. Taking systems thinking to the global level: using the WHO building blocks to describe and appraise the global health system in relation to COVID-19. Glob Policy. 2022;13(2):193-207. doi:1111/1758-5899.13081
  77. Bown CP. How COVID-19 medical supply shortages led to extraordinary trade and industrial policy. Asian Econ Policy Rev. 2022;17(1):114-135. doi:1111/aepr.12359
  78. Capuzzo M, Viganò GL, Boniotti C, Ignoti LM, Duri C, Cimolin V. Impact of the first phase of the COVID-19 pandemic on the acquisition of goods and services in the Italian health system. Int J Environ Res Public Health. 2022;19(4):2000. doi:3390/ijerph19042000
  79. Daly M, León M, Pfau-Effinger B, Ranci C, Rostgaard T. COVID-19 and policies for care homes in the first wave of the pandemic in European welfare states: too little, too late? J Eur Soc Policy. 2022;32(1):48-59. doi:1177/09589287211055672
  80. Garcia-Santaolalla N, de Klerk K. Ensuring market supply transparency for personal protective equipment: preparing for future pandemics. Glob Policy. 2022;13(3):401-411. doi:1111/1758-5899.13103
  81. Foo C, Verma M, Tan SM, et al. COVID-19 public health and social measures: a comprehensive picture of six Asian countries. BMJ Glob Health. 2022;7(11):e009863. doi:1136/bmjgh-2022-009863
  82. Gereffi G, Pananond P, Pedersen T. Resilience decoded: the role of firms, global value chains, and the state in COVID-19 medical supplies. Calif Manage Rev. 2022;64(2):46-70. doi:1177/00081256211069420
  83. Goyal Y. Public procurement during the pandemic: experience of India and China. J Public Procure. 2022;22(3):222-241. doi:1108/jopp-07-2021-0046
  84. Hoekman B, Shingal A, Eknath V, Ereshchenko V. COVID-19, public procurement regimes and trade policy. World Econ. 2022;45(2):409-429. doi:1111/twec.13118
  85. Kumar M, Fatma A, Bharti N. Access to medicines and medical equipment during COVID-19: searching compatibility between the WTO and the WHO. India Q. 2022;78(1):68-87. doi:1177/09749284211068461
  86. Li X, Hua G, Cheng TE, Choi TM. What does cross-industry-production bring under COVID-19? A multi-methodological study. IEEE Trans Eng Manag. 2022;71:1230-1244. doi:1109/tem.2022.3147815
  87. Meyer MM, Glas AH, Essig M. Learning from supply disruptions caused by SARS-CoV-2: use of additive manufacturing as a resilient response for public procurement. J Public Procure. 2022;22(1):17-42. doi:1108/jopp-11-2020-0079
  88. Ngo CN, Dang H. COVID-19 in America: global supply chain reconsidered. World Econ. 2023;46(1):256-275. doi:1111/twec.13317
  89. Pang PC, Jiang W, Pu G, Chan KS, Lau Y. Social media engagement in two governmental schemes during the COVID-19 pandemic in Macao. Int J Environ Res Public Health. 2022;19(15):8976. doi:3390/ijerph19158976
  90. Pircher B. EU public procurement policy during COVID-19: a turning point for legitimate EU governance? Politics and Governance. 2022;10(3):131-142. doi:17645/pag.v10i3.5295
  91. Falagara Sigala I, Sirenko M, Comes T, Kovács G. Mitigating personal protective equipment (PPE) supply chain disruptions in pandemics – a system dynamics approach. Int J Oper Prod Manag. 2022;42(13):128-154. doi:1108/ijopm-09-2021-0608
  92. Snowdon AW, Saunders MJ. Supply chain capacity to respond to COVID-19 in Newfoundland and Labrador: an integrated leadership strategy. Healthc Manage Forum. 2022;35(2):71-79. doi:1177/08404704211058414
  93. Winkelmann J, Webb E, Williams GA, Hernández-Quevedo C, Maier CB, Panteli D. European countries' responses in ensuring sufficient physical infrastructure and workforce capacity during the first COVID-19 wave. Health Policy. 2022;126(5):362-372. doi:1016/j.healthpol.2021.06.015
  94. Xu X, Choi TM, Chung SH, Shen B. Government subsidies and policies for mask production under COVID-19: is it wise to control less? IEEE Trans Eng Manag. 2022;71:3172-3188. doi:1109/tem.2022.3198101
  95. Yan R, Cao F. Improving public health and governance in COVID-19 response: a strategic public procurement perspective. Front Public Health. 2022;10:897731. doi:3389/fpubh.2022.897731
  96. Dube N, Li Q, Selviaridis K, Jahre M. One crisis, different paths to supply resilience: the case of ventilator procurement for the COVID-19 pandemic. J Purch Supply Manag. 2022;28(5):100773. doi:1016/j.pursup.2022.100773
  97. Gabet M, Duhoux A, Ridde V, Zinszer K, Gautier L, David PM. How did an integrated health and social services center in the Quebec province respond to the COVID-19 pandemic? A qualitative case study. Health Syst Reform. 2023;9(2):2186824. doi:1080/23288604.2023.2186824
  98. Grandia J, Warsen R. Procurement under pressure: shifting governance strategies in turbulent times. Public Manag Rev. 2023:1-19. doi:1080/14719037.2023.2281973
  99. Kubak M, Nemec P, Stefko R, Volosin M. On competition and transparency in public procurement during the COVID-19 pandemic in the European Union. E+M Ekon Manag. 2023;26(2):4-23. doi:15240/tul/001/2023-2-001
  100. Peters E, Knight L, Boersma K, Uenk N. Organizing for supply chain resilience: a high reliability network perspective. Int J Oper Prod Manag. 2023;43(1):48-69. doi:1108/ijopm-03-2022-0167
  101. Sevcík M, Smolík J, Brozová J, et al. The impact of the “first wave” of the COVID-19 pandemic on the municipalities in the South Moravian region: the mayor’s perspective. In: 26th International Colloquium on Regional Sciences. Brno: Masarykova Univerzita; 2023:340-348. doi:5817/cz.Muni.P280-0311-2023-40
  102. Beaulieu M, Ruel S, Dupouet O. Procurement-network contributions to healthcare supply chain resilience: a case study from Canada. Int J Public Sect Manag. 2024;37(5):712-728. doi:1108/ijpsm-12-2022-0280
  103. Boyer EJ. Responding to environmental uncertainties in critical supply acquisition: an examination of contracting for personal protective equipment (PPE) in the aftermath of COVID-19. J Public Adm Res Theory. 2024;34(2):301-315. doi:1093/jopart/muad015
  104. Boyer EJ, Rogers JD, Spampinato FC. Why modify or terminate contracts for critical supplies? Evaluating federal purchasing of PPE following COVID-19. Int Public Manag J. 2024;27(6):1017-1039. doi:1080/10967494.2024.2323606
  105. Handfield RB, Patrucco AS, Wu Z, Yukins C, Slaughter T. A new acquisition model for the next disaster: overcoming disaster federalism issues through effective utilization of the Strategic National Stockpile. Public Adm Rev. 2024;84(1):65-85. doi:1111/puar.13656
  106. Koligiannis G, Drakaki M, Tzionas P. Public procurement initiatives during the COVID-19 pandemic and lessons learned: the case study of Greece. J Public Procure. 2024;24(1):70-90. doi:1108/jopp-08-2023-0058
  107. Rufino Filho ET, Simoni Júnior S, Vettorato P. The incipient interstate cooperation in Brazilian federalism: an analysis of joint public procurement by consortia during the COVID-19 pandemic. Rev Serv Público. 2024;75(2):266-289. doi:21874/rsp.v75i2.10013
  108. Vogler S. Tackling medicine shortages during and after the COVID-19 pandemic: compilation of governmental policy measures and developments in 38 countries. Health Policy. 2024;143:105030. doi:1016/j.healthpol.2024.105030
  109. Li YY, Hong IH, Yang SJ. A public-private collaboration model of supply chain resilience to unpredictable disruptions: an exploratory empirical case study of medical mask production and distribution. Prod Plan Control. 2024;35(11):1298-1312. doi:1080/09537287.2023.2173104
  110. Dewick P, Hofstetter JS, Schröder P. From panic to dispassionate rationality—organizational responses in procurement after the initial COVID-19 pandemic peak. IEEE Eng Manag Rev. 2021;49(2):45-56. doi:1109/emr.2021.3079630

Files

History

  • Received Date: 24 April 2024
  • Revised Date: 06 June 2025
  • Accepted Date: 14 July 2025
  • First Published Date: 15 July 2025
  • Publish Date: 01 December 2025

Share

How to cite

Statistics